Sorry, you need to enable JavaScript to visit this website.

Susan Desmond-Hellmann, M.D., M.P.H

Senior Advisor and Board member of the Bill & Melinda Gates Medical Research Institute from 2020 until 2021. Former Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014 until 2020. Prior to joining the Bill & Melinda Gates Foundation, she was the first female and ninth overall Chancellor of the University of California, San Francisco (UCSF), from 2009 until 2014, where she still serves as an adjunct professor. From 1995 through 2009, Dr. Desmond-Hellmann was employed at Genentech where she served as President of Product Development from 2005 to 2009 overseeing pre-clinical and clinical development, business development and product portfolio management. Prior to joining Genentech, Dr. Desmond-Hellmann was Associate Director, Clinical Cancer Research at Bristol-Myers Squibb Pharmaceutical Research Institute. Director of Facebook Inc. from 2013 to 2019 and Procter & Gamble from 2010 to 2017. Board Member of Resilience, Inc. Pfizer Director since 2020. Member of our Governance & Sustainability and Science and Technology Committees.